Overview
Neuromuscular disorders can have a profound impact on individuals and their loved ones, but many people are unaware of the challenges faced by those affected. Moreover, there are numerous opportunities to improve care for these patients.
This activity offers the opportunity to gain a deeper understanding of the complex issues surrounding neuromuscular disorders. It will feature clinical experts discussing the state-of-the-science regarding clinical care of patients with neuromuscular disorders. Disease impact and the illness burden experienced by patients will be reviewed. Faculty will discuss best practices for evaluation of patients with a suspected neuromuscular disorder and keys to diagnosis. Focus will placed on sharing best management practices, including the rationale underpinning and supporting data for evidence-based practice.
Learning Objectives
- Describe the illness burden associated with neuromuscular disorders
- Outline best practices for evaluation and diagnosis of neuromuscular disorders
- Assess clinical data supporting evidence-based management of neuromuscular disorders
- Develop tailored management plans for patients with neuromuscular disorders
Target Audience
This educational activity is directed toward neuromuscular disease specialists, neurologists, specialty nurse practitioners (NPs), specialty physician assistants (PAs), nurses, and other HCPs involved in the care of patients with neuromuscular disorders.
James F. Howard Jr, MD, FAAN
Professor of Neurology, Medicine, and Allied Health
Director, Myasthenia Gravis Clinical Trials and Translational Research Program
UNC School of Medicine
The University of North Carolina at Chapel Hill
Chapel Hill, NC
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for Contact Hours.
Best Practices in the Diagnosis & Treatment of Amyotrophic Lateral Sclerosis (ALS)
Date: Saturday, September 19, 2026
Location: Join virtually or in person in Charlotte, NC
Venue: Omni Charlotte Hotel
Scientific Session: 8:10 AM - 9:10 AM ET
Patient, Provider, and Caregiver Connection™ – Alleviating the Disease Burden in ALS with Effective Multidisciplinary Care and Advance Care Planning
Date: Saturday, September 19, 2026
Location: Join virtually or in person in Charlotte, NC
Venue: Omni Charlotte Hotel
Scientific Session: 10:20 AM - 11:20 AM ET
Beyond the Basics in CIDP – Confronting Misdiagnosis and Rethinking Treatment Strategy
Date: Saturday, September 19, 2026
Location: Join virtually or in person in Charlotte, NC
Venue: Omni Charlotte Hotel
Scientific Session: 2:30 PM - 3:30 PM ET
Myasthenia Mimics – How to Differentiate Between Similar Neuromuscular Disorders
Date: Sunday, September 20, 2026
Location: Join virtually or in person in Charlotte, NC
Venue: Omni Charlotte Hotel
Scientific Session: 8:10 AM - 9:10 AM ET
What is Coming Down the Pipeline for Generalized Myasthenia Gravis (gMG)?
Date: Sunday, September 20, 2026
Location: Join virtually or in person in Charlotte, NC
Venue: Omni Charlotte Hotel
Scientific Session: 11:20 AM - 12:20 PM ET
A cancellation fee of 25% will be assessed on refunds requested 90 days before the start date, a 50% fee on refunds requested 60 days before the start date, and a 75% fee on refunds requested 30 days before the start date. No refunds will be made after 30 days before the start date. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.
In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.
PER® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting continuing education materials.